What is the risk of immediate complete revascularization versus staged revascularization for my heart attack?
If you had a heart attack (STEMI) and have blockages in more than one coronary artery, doctors must decide whether to fix all blockages during the same procedure (immediate complete revascularization) or wait and fix the non-culprit blockages in a separate procedure later (staged revascularization). Multiple recent studies and meta-analyses have compared these two approaches. The overall evidence shows that for most patients, the risks of major events like death, another heart attack, or stroke are similar between immediate and staged revascularization. However, staged revascularization may be linked to a higher chance of needing an unplanned repeat procedure to open a blockage again. For patients who also have heart failure at the time of their heart attack, immediate revascularization may carry higher risk.
What the research says
A 2024 meta-analysis of 11 randomized trials involving 4,472 patients found no significant difference between immediate and staged complete revascularization for major adverse cardiovascular events, all-cause mortality, cardiovascular mortality, recurrent heart attack, unplanned revascularization, or stent thrombosis at an average follow-up of 18.5 months 1. Another 2025 meta-analysis of 5 trials with 1,415 patients similarly found no significant differences in major adverse cardiovascular events, all-cause mortality, or heart attack, but did find that staged revascularization was associated with a higher rate of unplanned revascularization (8.6% vs 4.4%) 7. A 2024 network meta-analysis of 9 trials with 4,270 patients also showed no significant difference in major adverse cardiac events between immediate and staged in-hospital revascularization, but found higher odds of major adverse cardiac events with out-of-hospital staged revascularization compared to immediate revascularization 5. The 2-year follow-up data from the BIOVASC trial, which included 608 patients with ST-elevation acute coronary syndrome, showed no significant difference in the composite endpoint of death, heart attack, unplanned revascularization, or stroke between immediate and staged revascularization 6. However, a subgroup analysis from the OPTION-STEMI trial found that among patients with heart failure at admission, immediate complete revascularization was associated with a higher incidence of the composite endpoint (death, non-fatal heart attack, or unplanned revascularization) at 1 year compared to staged revascularization 4. Safety endpoints like stroke and major bleeding were comparable between the two strategies 1.
What to ask your doctor
- Given my specific blockages and overall health, is immediate or staged revascularization recommended for me?
- Do I have any signs of heart failure that might change the risk of immediate versus staged treatment?
- What is the typical timing for a staged procedure if we choose that approach?
- What are the chances I would need an unplanned repeat procedure with either strategy?
- How does my kidney function or other medical conditions affect the choice between immediate and staged revascularization?
This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.